2179 related articles for article (PubMed ID: 16826073)
1. Management of contralateral N0 neck in pyriform sinus carcinoma.
Koo BS; Lim YC; Lee JS; Kim YH; Kim SH; Choi EC
Laryngoscope; 2006 Jul; 116(7):1268-72. PubMed ID: 16826073
[TBL] [Abstract][Full Text] [Related]
2. Management of contralateral N0 neck in tonsillar squamous cell carcinoma.
Lim YC; Lee SY; Lim JY; Shin HA; Lee JS; Koo BS; Kim SH; Choi EC
Laryngoscope; 2005 Sep; 115(9):1672-5. PubMed ID: 16148715
[TBL] [Abstract][Full Text] [Related]
3. Treatment of contralateral N0 neck in early squamous cell carcinoma of the oral tongue: elective neck dissection versus observation.
Lim YC; Lee JS; Koo BS; Kim SH; Kim YH; Choi EC
Laryngoscope; 2006 Mar; 116(3):461-5. PubMed ID: 16540910
[TBL] [Abstract][Full Text] [Related]
4. Management of contralateral N0 neck in oral cavity squamous cell carcinoma.
Koo BS; Lim YC; Lee JS; Choi EC
Head Neck; 2006 Oct; 28(10):896-901. PubMed ID: 16721743
[TBL] [Abstract][Full Text] [Related]
5. Distributions of cervical lymph node metastases in oropharyngeal carcinoma: therapeutic implications for the N0 neck.
Lim YC; Koo BS; Lee JS; Lim JY; Choi EC
Laryngoscope; 2006 Jul; 116(7):1148-52. PubMed ID: 16826050
[TBL] [Abstract][Full Text] [Related]
6. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.
Spector JG; Sessions DG; Haughey BH; Chao KS; Simpson J; El Mofty S; Perez CA
Laryngoscope; 2001 Jun; 111(6):1079-87. PubMed ID: 11404625
[TBL] [Abstract][Full Text] [Related]
7. The influence of lymph node metastasis in the treatment of squamous cell carcinoma of the oral cavity, oropharynx, larynx, and hypopharynx: N0 versus N+.
Layland MK; Sessions DG; Lenox J
Laryngoscope; 2005 Apr; 115(4):629-39. PubMed ID: 15805872
[TBL] [Abstract][Full Text] [Related]
8. [Squamous-cell carcinoma of the tongue: treatment results and prognosis].
Zwetyenga N; Majoufre-Lefebvre C; Siberchicot F; Demeaux H; Pinsolle J
Rev Stomatol Chir Maxillofac; 2003 Feb; 104(1):10-7. PubMed ID: 12644785
[TBL] [Abstract][Full Text] [Related]
9. Is dissection of level IV absolutely necessary in elective lateral neck dissection for clinically N0 laryngeal carcinoma?
Lim YC; Choi EC; Lee JS; Koo BS; Song MH; Shin HA
Oral Oncol; 2006 Jan; 42(1):102-7. PubMed ID: 16143563
[TBL] [Abstract][Full Text] [Related]
10. [Impact of extracapsular lymph node spread in the ipsilateral neck on contralateral neck metastasis and prognosis of laryngeal cancer].
Liu B; Guan C; Ji WY; Pan ZM
Zhonghua Zhong Liu Za Zhi; 2006 Nov; 28(11):871-5. PubMed ID: 17416015
[TBL] [Abstract][Full Text] [Related]
11. Level V lymph node dissection in oral and oropharyngeal carcinoma patients with clinically node-positive neck: is it absolutely necessary?
Lim YC; Koo BS; Lee JS; Choi EC
Laryngoscope; 2006 Jul; 116(7):1232-5. PubMed ID: 16826066
[TBL] [Abstract][Full Text] [Related]
12. Level IIb lymph node metastasis in laryngeal squamous cell carcinoma.
Lim YC; Lee JS; Koo BS; Choi EC
Laryngoscope; 2006 Feb; 116(2):268-72. PubMed ID: 16467717
[TBL] [Abstract][Full Text] [Related]
13. Parotid metastasis--an independent prognostic factor for head and neck cutaneous squamous cell carcinoma.
Ch'ng S; Maitra A; Lea R; Brasch H; Tan ST
J Plast Reconstr Aesthet Surg; 2006; 59(12):1288-93. PubMed ID: 17113505
[TBL] [Abstract][Full Text] [Related]
14. Contralateral lymph neck node metastasis of squamous cell carcinoma of the oral cavity: a retrospective analytic study in 315 patients.
González-García R; Naval-Gías L; Rodríguez-Campo FJ; Sastre-Pérez J; Muñoz-Guerra MF; Gil-Díez Usandizaga JL
J Oral Maxillofac Surg; 2008 Jul; 66(7):1390-8. PubMed ID: 18571022
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic selective neck dissection (level II-V) for node-positive hypopharyngeal carcinoma: is it oncologically safe?
Lim YC; Lee JS; Choi EC
Acta Otolaryngol; 2009 Jan; 129(1):57-61. PubMed ID: 18607981
[TBL] [Abstract][Full Text] [Related]
16. Significance of clinical stage, extent of surgery, and pathologic findings in metastatic cutaneous squamous carcinoma of the parotid gland.
O'Brien CJ; McNeil EB; McMahon JD; Pathak I; Lauer CS; Jackson MA
Head Neck; 2002 May; 24(5):417-22. PubMed ID: 12001070
[TBL] [Abstract][Full Text] [Related]
17. The effect of occult nodal metastases on survival and regional control in patients with head and neck squamous cell carcinoma.
Gourin CG; Conger BT; Porubsky ES; Sheils WC; Bilodeau PA; Coleman TA
Laryngoscope; 2008 Jul; 118(7):1191-4. PubMed ID: 18391764
[TBL] [Abstract][Full Text] [Related]
18. Lymphatic metastases to level IIb in hypopharyngeal squamous cell carcinoma.
Kim YH; Koo BS; Lim YC; Lee JS; Kim SH; Choi EC
Arch Otolaryngol Head Neck Surg; 2006 Oct; 132(10):1060-4. PubMed ID: 17043251
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors influencing contralateral neck lymph node metastases in oral and oropharyngeal carcinoma.
Capote-Moreno A; Naval L; Muñoz-Guerra MF; Sastre J; Rodríguez-Campo FJ
J Oral Maxillofac Surg; 2010 Feb; 68(2):268-75. PubMed ID: 20116694
[TBL] [Abstract][Full Text] [Related]
20. Treatment of patients with clinically lymph node-negative squamous cell carcinoma of the oral cavity.
Jang WI; Wu HG; Park CI; Kim KH; Sung MW; Kim MJ; Choung PH; Lee JH; Choi JY
Jpn J Clin Oncol; 2008 Jun; 38(6):395-401. PubMed ID: 18573849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]